Normative Brain Volume Profiles From Multicenter Fetal MRI (MULTINORMFET)
Courbes Normatives De Volumes Cérébraux Issues D'IRM Fœtales Multicentriques
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Nadine Girard, Pr
- Phone Number: 0413429061
- Email: nadine.girard@ap-hm.fr
Study Contact Backup
- Name: Aurélie Ponz
- Phone Number: 0491435196
- Email: aurelie.ponz@ap-hm.fr
Study Locations
-
-
-
Marseille, France, 13005
- Recruiting
- Chu Timone
-
Contact:
- Nadine GIRARD, MD PHD
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
Child who has had, more than 3 years ago, a cerebral MRI during the fetal period in one of the 4 partner centers
Exclusion Criteria:
- Child suffering from a commissural malformation (anomaly of the corpus callosum)
- Child with a genetic syndrome and/or chromosomal abnormality and/or deleterious mutation
- Child with syndromic extra-cerebral malformations (including cardiac malformations)
- Child with intrauterine growth restriction reported in the obstetrical record
- Child with maternal-fetal infection (TORCH, parvovirus or other) confirmed by amniotic fluid test or neonatal urine test
- Multiple pregnancy
- Mother with diabetes treated during pregnancy (including gestational diabetes, if treated)
- Mother with antiepileptic medication during pregnancy
- Alcohol or drug use
- Presence of a sustentorial arachnoid cyst
- Presence of an arachnoid cyst with mass effect
- Objection from parental authority holders to participate in the study
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Determine normative brain volume curves
Time Frame: Through study completion, an average of 3 year
|
Curves calculated from fetal brain MRIs in fetuses between 20 and 37 weeks of amenorrhea with normal postnatal neurological development
|
Through study completion, an average of 3 year
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Statistically compare the normative curves obtained with standard articles in the literature.
Time Frame: Through study completion, an average of 3 year
|
Comparaison of Size effect, confidence intervals obtained with those reported in the reference articles
|
Through study completion, an average of 3 year
|
|
Sensitivity study: Possible influence of the scanner type on the estimated normative curves.
Time Frame: Through study completion, an average of 3 year
|
MRI scanner model
|
Through study completion, an average of 3 year
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- RCAPHM22_0324
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.